In the dynamic world of pediatric oncology, the Nephroblastoma Treatment Market is rapidly gaining traction. Nephroblastoma, commonly known as Wilms tumor, is the most prevalent form of kidney cancer in children. With increasing awareness, improved early diagnosis, and groundbreaking innovations in treatment, this niche market is poised for remarkable growth over the next decade....